Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash from Operations (2019 - 2025)

Outset Medical (OM) has disclosed Cash from Operations for 7 consecutive years, with 9521000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 42.25% to 9521000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 46327000.0, a 60.17% increase, with the full-year FY2025 number at 46327000.0, up 60.17% from a year prior.
  • Cash from Operations was 9521000.0 for Q4 2025 at Outset Medical, down from 6320000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 4823000.0 in Q2 2025 to a low of 45912000.0 in Q1 2024.
  • A 5-year average of 28499800.0 and a median of 31758500.0 in 2021 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: crashed 60.92% in 2021, then skyrocketed 85.53% in 2025.
  • Outset Medical's Cash from Operations stood at 32676000.0 in 2021, then dropped by 5.6% to 34507000.0 in 2022, then grew by 29.17% to 24442000.0 in 2023, then surged by 32.54% to 16488000.0 in 2024, then skyrocketed by 42.25% to 9521000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Cash from Operations are 9521000.0 (Q4 2025), 6320000.0 (Q3 2025), and 4823000.0 (Q2 2025).